Trial Profile
Blinded, Randomized Study of Gabapentin (Neurontin(R)) and Gabapentin Enacarbil (Horizant(TM)) in Restless Leg Syndrome
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary) ; Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 28 Jun 2016 Status changed from recruiting to discontinued.
- 11 Apr 2016 Planned End Date changed from 1 Oct 2015 to 1 Dec 2016.
- 11 Apr 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Dec 2016.